Type | Description |
---|---|
Definition | SYF2 pre-mRNA splicing factor |
Date | Results | Publications |
---|---|---|
2020-10-24 13:59:00 | LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621. | 31799663 |
2020-05-23 10:48:00 | These data identify Aletrnative splicing programs controlled by ZRANB2 and SYF2 and converging on ECT2, that participate to breast cancer cell resistance to doxorubicin. | 31943118 |
2020-02-29 11:31:00 | These results showed that microRNA-376c-3p inhibits the proliferation and migration of gastric cancer cells via targeting SYF2. | 31522605 |
2016-08-20 11:27:00 | SYF2 might play a regulatory role in the proliferation of hepatocellular carcinoma cells. | 26260052 |
2015-10-24 11:27:00 | we support that SYF2 might contribute to EOC progression via modulation of proliferation in EOC cells and would provide a novel therapeutic target of human epithelial ovarian cancer | 25623116 |
Type | IDs |
---|---|
Synonymous | CBPIN, NTC31, P29, fSAP29 |
Gene |
UniProtKB-ID:
SYF2_HUMAN
UniprotKB:
O95926
UniParc:
UPI00003588BA,
UPI0000073D39
EMBL:
AL031432,
BC010862,
AF273089,
AL080166
Ensembl:
ENSG00000117614
KO:
hsa:25949
|
Nucleutide sequences |
EMBL-CDS:
CAB45754.1,
AAH10862.1,
AAG42073.1
Ensembl_TRS:
ENST00000236273,
ENST00000354361
|
Protein sequencees |
Ensembl_PRO:
ENSP00000346330,
ENSP00000236273
RefSeq:
NP_997053.1,
NP_056299.1
|
Others |
UniRef100:
UniRef100_O95926
UniRef90:
UniRef90_O95926
UniRef50:
UniRef50_O95926
UniGene:
Hs.20013
CCDS:
CCDS258.1,
CCDS259.1
|
{{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
---|---|---|---|---|---|---|---|---|
Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
暂无数据
排名 | 科研单位 | 文献 |
---|---|---|
{{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
排名 | 研究人员 | 文献 |
---|---|---|
{{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员